Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05562388 · ClinicalTrials.gov registry record · NA
Mandibular Advancement Device and Changes in Nocturia
A NA study of Obstructive Sleep Apnea and OSA, sponsored by Fernanda Yanez Regonesi.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05562388: Recruiting NA study of Obstructive Sleep Apnea and OSA, sponsored by Fernanda Yanez Regonesi.
NCT05562388 is a NA study of Obstructive Sleep Apnea and OSA that is actively recruiting participants, run by Fernanda Yanez Regonesi. The registered enrollment target is 36 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05562388, a NA study of Obstructive Sleep Apnea and OSA, is actively recruiting participants, sponsored by Fernanda Yanez Regonesi.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to test is mandibular advacenment device (MAD) use is associated with reductions in nocturia.
Primary Outcome
Assessment of efficacy of device in terms of nocturia: Patients will complete daily questionnaires to evaluate voiding at night. Average of 2 preceding weeks of the follow up will be used to determine treatment success in terms of nocturia. Once less than 2 voiding's per night is achieved participants will be considers responders in terms of nocturia and second sleep study will be performed.
Conditions Studied
Interventions
- DEVICE Somnodent Classic
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-12-11 |
| Est. Completion | 2026-03-12 |
| Phase | NA |
What NCT05562388 shows while recruiting
NCT05562388 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (84% lower).
The record links to 3 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Somnodent Classic is the first listed.
NCT05562388 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05562388 about?
NCT05562388 is a clinical study titled "Mandibular Advancement Device and Changes in Nocturia". The main purpose of this study is to test is mandibular advacenment device (MAD) use is associated with reductions in nocturia.
What is the current status of trial NCT05562388?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-12-11. Estimated completion is 2026-03-12.
What conditions does trial NCT05562388 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, OSA, Nocturia.
What interventions are being tested in trial NCT05562388?
The interventions under investigation include: Somnodent Classic (DEVICE).
Who is sponsoring clinical trial NCT05562388?
This trial is sponsored by Fernanda Yanez Regonesi, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05562388 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05562388's enrollment target sits among peer trials
36 122nd of 155 higher than 31 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
-
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI